Linka Xie

669 total citations
17 papers, 533 citations indexed

About

Linka Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Linka Xie has authored 17 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Linka Xie's work include FOXO transcription factor regulation (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and HER2/EGFR in Cancer Research (3 papers). Linka Xie is often cited by papers focused on FOXO transcription factor regulation (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and HER2/EGFR in Cancer Research (3 papers). Linka Xie collaborates with scholars based in China, Germany and United States. Linka Xie's co-authors include Hanfeng Guan, Thomas Wirth, Alexey Ushmorov, Peter Möller, Frank Leithäuser, Marion Vogel, Christian Steidl, Harald J. Maier, Randy D. Gascoyne and Ming‐Hua Zheng and has published in prestigious journals such as Blood, Scientific Reports and Spine.

In The Last Decade

Linka Xie

15 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linka Xie China 11 360 165 149 92 71 17 533
Hye Ree Kim South Korea 13 254 0.7× 123 0.7× 187 1.3× 62 0.7× 29 0.4× 33 501
Areumnuri Kim South Korea 13 250 0.7× 160 1.0× 97 0.7× 78 0.8× 33 0.5× 22 404
Hui-Lan Rao China 11 264 0.7× 105 0.6× 142 1.0× 71 0.8× 34 0.5× 13 482
Yanfeng Liu China 11 242 0.7× 163 1.0× 115 0.8× 35 0.4× 56 0.8× 41 486
Arshad A. Pandith India 14 323 0.9× 114 0.7× 139 0.9× 47 0.5× 35 0.5× 68 604
Claire Bléchet France 12 194 0.5× 140 0.8× 164 1.1× 44 0.5× 36 0.5× 27 470
Jia-Hong Chen Taiwan 11 180 0.5× 118 0.7× 73 0.5× 48 0.5× 27 0.4× 29 383
Wioletta Pękala Poland 11 505 1.4× 192 1.2× 230 1.5× 95 1.0× 19 0.3× 15 689
Yanjie Xu China 11 248 0.7× 98 0.6× 49 0.3× 67 0.7× 125 1.8× 45 514

Countries citing papers authored by Linka Xie

Since Specialization
Citations

This map shows the geographic impact of Linka Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linka Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linka Xie more than expected).

Fields of papers citing papers by Linka Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linka Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linka Xie. The network helps show where Linka Xie may publish in the future.

Co-authorship network of co-authors of Linka Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Linka Xie. A scholar is included among the top collaborators of Linka Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linka Xie. Linka Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
Huang, Kecheng, Linka Xie, & Fan Wang. (2022). A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia. Genes. 13(12). 2281–2281. 4 indexed citations
4.
Dong, Yimin, Linka Xie, Honglei Kang, et al.. (2021). A Competing Risk-based Prognostic Model to Predict Cancer-specific Death of Patients with Spinal and Pelvic Chondrosarcoma. Spine. 46(22). E1192–E1201. 4 indexed citations
5.
Ma, Yuxi, Zihan Xia, Chong Lu, et al.. (2019). AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion. Aging. 11(12). 3969–3992. 35 indexed citations
6.
Wang, Bi‐Cheng, et al.. (2019). Comparative Toxicities of Neoadjuvant Chemotherapy With or Without Bevacizumab in HER2-Negative Breast Cancer Patients: A Meta-analysis. Annals of Pharmacotherapy. 54(6). 517–525. 4 indexed citations
7.
Xie, Linka, Hanfeng Guan, Franziska Herrmann, et al.. (2018). Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation. Blood. 131(14). 1556–1567. 16 indexed citations
8.
Liu, Zhao, Chen Mi, Linka Xie, et al.. (2018). CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling. Aging. 10(10). 2570–2584. 29 indexed citations
9.
Liu, Cuiwei, Zhongyuan Yin, Ting Hu, et al.. (2018). Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy. Medicine. 97(30). e11588–e11588. 18 indexed citations
10.
Guan, Hanfeng, Linka Xie, Thomas Wirth, & Alexey Ushmorov. (2016). Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis. Oncotarget. 7(24). 36854–36864. 7 indexed citations
11.
You, Jie, Gui‐Qi Zhu, Linka Xie, et al.. (2016). Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer. Oncotarget. 7(18). 25516–25527. 58 indexed citations
12.
Guan, Hanfeng, et al.. (2015). FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC. Scientific Reports. 5(1). 16835–16835. 34 indexed citations
13.
Xie, Linka, Olga Ritz, Frank Leithäuser, et al.. (2014). FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma. Oncotarget. 5(14). 5392–5402. 13 indexed citations
14.
Vogel, Marion, Linka Xie, Hanfeng Guan, et al.. (2014). FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. Blood. 124(20). 3118–3129. 32 indexed citations
15.
Guan, Hanfeng, et al.. (2013). Decitabine represses translocated MYC oncogene in Burkitt lymphoma. The Journal of Pathology. 229(5). 775–783. 28 indexed citations
16.
Xie, Linka, Alexey Ushmorov, Frank Leithäuser, et al.. (2012). FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood. 119(15). 3503–3511. 141 indexed citations
17.
Guan, Hanfeng, Linka Xie, Frank Leithäuser, et al.. (2010). KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood. 116(9). 1469–1478. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hye Ree Kim Breakdown of academic impact, for papers by Areumnuri Kim Breakdown of academic impact, for papers by Hui-Lan Rao Breakdown of academic impact, for papers by Yanfeng Liu Breakdown of academic impact, for papers by Arshad A. Pandith Breakdown of academic impact, for papers by Claire Bléchet Breakdown of academic impact, for papers by Jia-Hong Chen Breakdown of academic impact, for papers by Wioletta Pękala Breakdown of academic impact, for papers by Yanjie Xu
Rankless by CCL
2026